| Medical and Health Sciences | Lifetime | 104 | US 57 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 168 | US 63 | 99.97 |
| Nephrology | Lifetime | 6 | US 4 | 99.97 |
| Emergency Medical Services | Lifetime | 60 | US 33 | 99.18 |
| Surgery | Lifetime | 829 | US 445 | 99.21 |
| Econometrics and Quantitative Economics | Lifetime | 979 | US 539 | 99.10 |
| Pulmonary and Respiratory Medicine | Lifetime | 587 | US 310 | 99.16 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 364 | US 201 | 98.91 |
| Cardiology and Cardiovascular Medicine | Lifetime | 656 | US 344 | 98.84 |
| Pediatrics, Perinatology and Child Health | Lifetime | 743 | US 366 | 97.64 |
| Hematology | Lifetime | 546 | US 273 | 96.01 |
| Transplantation | Lifetime | 250 | US 119 | 92.29 |
| Nephrology | 2021-2025 | 8 | US 2 | 99.84 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 32 | US 21 | 99.65 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 374 | US 119 | 96.31 |
| Surgery | 2021-2025 | 521 | US 203 | 95.72 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 363 | US 172 | 95.93 |
| Hematology | 2021-2025 | 191 | US 89 | 93.91 |
| Transplantation | 2021-2025 | 107 | US 52 | 75.00 |
| Dialysis and Renal Disease Management | Lifetime | 2 | US 2 | 99.97 |
| Parathyroid Disorders and Treatments | Lifetime | 2 | US 2 | 99.92 |
| Acute Kidney Injury Research | Lifetime | 5 | US 3 | 99.92 |
| Central Venous Catheters and Hemodialysis | Lifetime | 6 | US 4 | 99.85 |
| Chronic Kidney Disease and Diabetes | Lifetime | 5 | US 3 | 99.91 |
| Renal and Vascular Pathologies | Lifetime | 15 | US 13 | 99.73 |
| Magnesium in Health and Disease | Lifetime | 7 | US 3 | 99.33 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 127 | US 62 | 99.54 |
| Potassium and Related Disorders | Lifetime | 14 | US 10 | 99.66 |
| Muscle and Compartmental Disorders | Lifetime | 17 | US 8 | 99.42 |
| Nutrition and Health in Aging | Lifetime | 154 | US 67 | 99.24 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 116 | US 48 | 99.20 |
| Diabetes Treatment and Management | Lifetime | 141 | US 66 | 99.39 |
| Iron Metabolism and Disorders | Lifetime | 102 | US 47 | 99.02 |
| Renal function and acid-base balance | Lifetime | 66 | US 34 | 98.77 |
| Sepsis Diagnosis and Treatment | Lifetime | 139 | US 53 | 99.27 |
| Erythropoietin and Anemia Treatment | Lifetime | 43 | US 18 | 99.08 |
| Blood Pressure and Hypertension Studies | Lifetime | 225 | US 104 | 99.26 |
| Neurological and metabolic disorders | Lifetime | 48 | US 22 | 98.53 |
| Body Composition Measurement Techniques | Lifetime | 104 | US 42 | 98.79 |
| Pancreatic function and diabetes | Lifetime | 436 | US 196 | 98.69 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 300 | US 157 | 98.68 |
| Organ Donation and Transplantation | Lifetime | 198 | US 115 | 98.24 |
| Hemodynamic Monitoring and Therapy | Lifetime | 299 | US 114 | 98.13 |
| Heart Failure Treatment and Management | Lifetime | 409 | US 198 | 98.49 |
| Healthcare Policy and Management | Lifetime | 387 | US 280 | 98.07 |
| Vitamin D Research Studies | Lifetime | 260 | US 128 | 98.04 |
| Hemoglobinopathies and Related Disorders | Lifetime | 621 | US 318 | 97.07 |
| Healthcare cost, quality, practices | Lifetime | 318 | US 179 | 96.07 |
| Renal Diseases and Glomerulopathies | Lifetime | 703 | US 241 | 96.94 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 355 | US 174 | 96.21 |
| Electrolyte and hormonal disorders | Lifetime | 586 | US 279 | 95.43 |
| Frailty in Older Adults | Lifetime | 758 | US 270 | 95.34 |
| Genetic Syndromes and Imprinting | Lifetime | 878 | US 330 | 92.39 |
| Aortic Thrombus and Embolism | Lifetime | 134 | US 65 | 89.48 |
| Biomedical Research and Pathophysiology | Lifetime | 685 | US 277 | 87.73 |
| Sodium Intake and Health | Lifetime | 980 | US 386 | 87.69 |
| Restless Legs Syndrome Research | Lifetime | 742 | US 216 | 83.68 |
| Therapeutic Uses of Natural Elements | Lifetime | 884 | US 192 | 77.93 |
| Dialysis and Renal Disease Management | 2021-2025 | 5 | US 1 | 99.73 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 10 | US 5 | 99.66 |
| Pancreatic function and diabetes | 2021-2025 | 22 | US 14 | 99.33 |
| Diabetes Treatment and Management | 2021-2025 | 44 | US 27 | 99.54 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 10 | US 6 | 98.54 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 59 | US 21 | 98.56 |
| Parathyroid Disorders and Treatments | 2021-2025 | 49 | US 16 | 97.56 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 130 | US 53 | 97.43 |
| Potassium and Related Disorders | 2021-2025 | 25 | US 12 | 97.76 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 134 | US 44 | 95.36 |
| Electrolyte and hormonal disorders | 2021-2025 | 61 | US 23 | 93.63 |
| Renal and Vascular Pathologies | 2021-2025 | 143 | US 49 | 93.31 |
| Magnesium in Health and Disease | 2021-2025 | 25 | US 3 | 92.10 |
| Diabetes Management and Research | 2021-2025 | 555 | US 224 | 93.89 |
| Neurological and metabolic disorders | 2021-2025 | 57 | US 14 | 84.95 |
| Acute Kidney Injury Research | 2021-2025 | 326 | US 96 | 88.55 |
| Heart Failure Treatment and Management | 2021-2025 | 997 | US 295 | 89.13 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 663 | US 301 | 88.23 |
| Renal Transplantation Outcomes and Treatments | 2021-2025 | 989 | US 452 | 86.57 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 613 | US 194 | 80.85 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 756 | US 164 | 75.13 |
| Renal function and acid-base balance | 2021-2025 | 828 | US 228 | 51.80 |
| Heart rate and cardiovascular health | 2021-2025 | 301 | US 52 | 23.94 |
| Cynara cardunculus studies | 2021-2025 | 261 | US 14 | 25.73 |
